Abstract
Cardiac arrhythmias probably underlie the majority of incidents of sudden cardiac death. Data from out-of-hospital rescue squads1,2, from coronary care units3 and from chance events captured on dynamic ECG recorders4 show that ventricular tachyarrhythmias (ventricular tachycardia, ventricular flutter and ventricular fibrillation) are the commonest arrhythmias implicated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schaffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. New Eng J Med 293:259–262, 1975
Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR, Blackbourne 3D, Davis JH. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation 49:790–798, 1974
Julian DG, Valentine PA, Miller GG. Disturbances of rate rhythm and conduction in acute myocardial infarction. Am J Med 37:915–927, 1964
Roelandt J, Klootwijk J, Lumsen J, Janse MJ. Sudden death during long term ambulatory monitoring. Eur Heart J 5:7–20, 1984
Adgey AAJ, Allen JD, Geddes JS, James RGG, Webb SW, Zaida SA, Pantridge JF. Acute phase of myocardial infarction. Lancet 2:501–504, 1971
Lie KI, Liem KL, Schuilenberg RM, David GK, Durrer D. Early identification of patients developing late in-hospital ventricular fibrillation after discharge from the coronary care unit. A 5.5 year retrospective study of 1897 patients. Am J Cardiol 41:674–677, 1978
Hauer RNW, Lie KI, Liem KL, Durrer D. Long-term prognosis in patients with bundle branch block complicating acute anteroseptal infarction. Am J Cardiol 49:1581–1585, 1982.
Geddes JS, Adgey AAJ, Pantridge JF. Prognosis after recovery from ventricular fibrillation complicating ischaemic heart disease. Lancet 2:273–275, 1969.
McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy: I Influence on prognosis. Br Heart J 46:168–172, 1981.
Horowitz LN, Josephson ME, Kastor JA. Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog Cardiovasc Dis 23:81–98, 1980.
Campbell RWF. Does non beta-blocking antiarrhythmic therapy prevent sudden cardiac death? In:Morganroth J, Moore EN (eds) Sudden death and congestive heart failure: diagnosis and treatment. Martinus Nijhoff, The Hague, 1983, pp l40–154.
Myerburg RJ, Conde C, Sheps DS, Appel RA, Kiem I, Sung RJ, Castellanos A. Antiarrhythmic drug therapy in survivors of pre-hospital cardiac arrest: comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest. Circulation 59:855–863, 1979.
Ruskin JN, DiMarco JP, Garan H. Out-of-hospital cardiac arrest. N Engl J Med 30:607–613, 1980.
Horn HR, Hadidian Z, Johnson JL, Vassallo HG, Williams JH, Young MD. III. Chronic tocainide therapy studies. Safety evaluation of tocainide in the American emergency use program. Am Heart J 100:1037–1040, 1980.
Ryden L, Ariniego R, Amman K, Herlitz J, Hjalmarson A, Holberg S, Reyes C, Smedgard P, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C, Wedel H, Yamamoto M. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. New Engl J Med 308:614–618, 1983.
The Norwegian Muticenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New Engl J med 304:801–807, 1981.
B-Blocker Heart Attack Trial Research Group. A randomized trial of propranalol in patients with acute myocardial infarction. JAMA 247:1707–1714, 1982.
Hjalmarson A, Herlitz J, Malek I, Ryden L, Vedin A, Waldenstrom A, Wedel H, Elmfeldt D, Holmberg S, Nyberg G, Swedberg K, Waagstein F, Waldenstrom J, Wilhelmsen L, Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction. A double blind randomized trial. Lancet 2:823–827, 1981.
Schwartz PJ. The idiopathic long QT syndrome. The need for a prospective registry. Eur Heart J 4:529–531, 1983
McKenna WJ. Arrhythmia and prognosis in hypertrophic cardiomyopathy. Eur Heart J 4(suppl F): 225–234, 1983.
Winkle RA, Mason JW, Griffin JC, Ross D. Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J 102:854–864, 1981.
Nicholson MR, Campbell RWF, Julian DG. Ventricular tachycardia — management with encainide.(abs) Circulation 64:37, 1981
Kennelly BM. Comparison of lidoflazine and quinidine in prophylactic treatment of arrhythmias. Br Heart J 39:540–546, 1977.
Ruskin JN, McGovern B, Garan H, DiMarco JP, Kelly E. Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med 309:1302–1306, 1983.
Denes P, Gabster A, Huang SK. Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy. Am J Cardiol 48:9–16, 1981.
McGovern B, Garan H, Kelly, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J 287:175–180, 1983
Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RAJ, Camm AJ. Proarrhythmic effect of the new antiarrhythmic agent flecainide acetate. Am Heart J 107:222–228, 1984.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Campbell, R.W.F. (1985). Sudden Cardiac Death — Failure or Effect of Antiarrhythmic Drug Therapy?. In: Morganroth, J., Moore, E.N. (eds) Cardiac Arrhythmias: New Therapeutic Drugs and Devices. Developments in Cardiovascular Medicine, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2595-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2595-6_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9626-3
Online ISBN: 978-1-4613-2595-6
eBook Packages: Springer Book Archive